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Available online 12 November 2014AbstractImmunocompromised patients are subject to a variety of infectious pathogens involving lungs. Imaging examination of pulmonary conditions
could provide valuable information for differentiation diagnosis, treatment assessment as well as prognostic prediction. Imaging manifestations
of immunocompromise-related pulmonary diseases could be either pathogen-specific or -non-specific. It is particularly fundamental to recognize
these imaging characteristics at suspicion of opportunistic infections in such patients. In this article, we attempt to present a review to refresh and
update our knowledge of imaging features of pulmonary infectious diseases in immunocompromised patients.
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various disorders impairing human immune systems, including
human immunodeficiency virus (HIV) infection, primary im-
mune deficiency, and immunosuppression-related medical
treatment, such as high-dose corticosteroid use, chemotherapy
or transplantation therapy [1]. Among them, HIV infections and
consequent AIDS are the most notorious. Since first recognized
in 1981, HIV infection has became a global healthcare chal-
lenge, being responsible for the death of over 25 million pa-
tients. Currently around 33.3 million people are suffering from
HIV infection and its associated complications [2]. Clinical
complications in immunocompromised patients vary from se-
vere opportunistic infections to unusual malignancies affecting
major organs. Fig. 1 outlines the major classes of immuno-
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the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Most of imaging modalities available today have certain
roles in the evaluation of the pulmonary complications
occurring in immunocompromised patients. For example, ul-
trasound can be used for quantitation of pleural effusion and
guiding thoracentesis, if necessary. There have been interests
in the roles of MRI in evaluating immunocompromised
patients e many are young and there is concern about
frequent imaging using ionizing radiation. Still, chest radio-
graph and CT or high-resolution CT (HRCT) remain the most
useful tools. Particularly, cross sectional images from CT or
sometimes HRCT, enables better precise characterization of
the extent, activity and pattern of pulmonary lesions, guides
tissue biopsy whenever necessary, and monitors treatment
response. A normal CT may allow exclusion of certain
infections, for example pneumocystis, but certain pathogen-
related pulmonary infection could be negative in imaging at
the initial developing phase of the disease, for example fungal
infections. Thus, imaging examination should always be
interpreted in the context of the patient's clinical presentation.
Table 1 lists the common imaging patterns seen in HRCT
examination and frequently underlying infections. In this. Production and hosting by Elsevier B.V. This is an open access article under
Fig. 1. Major classes of immunocompromised conditions, related clinical entities and infections most commonly associated with each class (Baughman RP [3]).
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acteristics of pulmonary infectious diseases in this particular
patient population.
1. Bacterial pneumonia
Mycobacterial infection, including both tuberculosis (TB)
and non-tuberculous mycobacterial infection, is an important
cause of morbidity and mortality in immunocompromised
patients, particularly in AIDS patients. According to a report
from the World Health Organization in 2009, among the 9.27
million cases of TB, approximately 14.8% occurred in HIV-
positive patients with about half of million deaths from HIV-
infected TB patients. Fatality rate among HIV-infected TB
cases remains 13e14% against less than 4% in HIV negative
TB cases [4]. The most common HRCT findings in active TBTable 1
Common HRCT imaging patterns with frequent immunocompromise-related
infections.
Imaging patterns Associated infections
Ground-glass opacity  Pneumocystis
 Cytomegalovirus
Nodules <1 cm diameter  Viral pneumonia
>1 cm diameter  Invasive aspergillosis
 Septic embolism
“Halo sign”  Invasive aspergillosis
 Candidiasis
 Cytomegalovirus pneumonia
Cavitated nodules  Septic embolism
 Invasive aspergillosis
Tree-in-bud pattern  Infectious bronchiolitis
Consolidation Lobar  Pneumococcus
 Klebsiella
Rounded  Pneumococcus
 Legionella
Bronchopneumonia  Gram-negative bacteria
 Staphylococcusare centrilobular or linear structures, tree-in-bud appearance
and macro-nodules. Consolidation, lymphadenopathy, pleural
effusion, ground glass opacity and cavitation also can be
observed [5]. In smear-negative AIDS patients with pulmonary
TB, specific CT findings have predictive values for accurate
diagnosis. These findings include miliary nodules, necrotic
lymph nodes, lobular consolidation and tree-in-bud [6]. Of
note, unusual radiographic manifestations of TB are more
common in immunocompromised patients than in immuno-
competent populations.
The most common non-tuberculous mycobacteria involving
lungs is mycobacterium avium complex (MAC). According to
a study by the Centers of Disease Control of United States
from 1991 through 1992, MAC dominated M. tuberculosis as
the leading mycobacterium isolated from immunocompro-
mised patients, particularly since pneumocystis prophylaxis
was widely given [7]. It has been reported that MAC infection
developed in 33.4% of HIV-infected patients, with predispo-
sition of developing disseminated diseases, involving extrap-
ulmonary organs, such as kidney and liver [8]. However,
incidence of MAC infection is quite low in non-HIV immu-
nocompromised patients. Localized pulmonary disease is rare,
only seen in less than 5% of patients. Radiographic findings
dramatically vary, ranging from normal to mediastinal
lymphadenopathy, lobar infiltrates, diffuse or patchy nodular
or alveolar infiltrates, without specific imaging patterns asso-
ciated with MAC infection [9]. Clinically, low CD4 counts less
than 50 cells/mm3 could be indicative of this disease when
non-specific pulmonary involvement exists.
According to the Pulmonary Complications of HIV Infec-
tion Study, increased incidence of community-acquired bac-
terial pneumonia (CAP) was associated with HIV infection
with 5.5 episodes of pneumonia per hundred person years in
HIV-infected patients in comparison with 0.9 episodes in the
non-HIV group [10]. However, with the development of an-
tiretroviral treatment, the incidence of CAP in
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pneumoniae and Haemophilus pneumonia are the common
pathogens.
Radiographically, lobar or multi-lobar consolidation is the
major imaging finding, observed in 45e66% of patients with
pyogenic infections [11]. Certainly, HRCT has higher sensi-
tivity in detecting abnormalities in the absence of any con-
ventional radiographic change. HRCT findings include
bronchiectasis and evidence of small-airway disease, with ill-
defined centrilobular micro-nodules and branching structures
or tree-in-bud appearance secondary to mucus impaction [12].
Other imaging characteristics, such as mosaic attenuation due
to air trapping, diffuse alveolar involvement and interstitial
infiltrates may be seen. Regardless of antiretroviral treatment,
no significant differences in the findings of CAP were found in
HIV-infected patients [13].
Occurring predominantly in immunosuppressed patients,
nocardosis is uncommon but frequently fatal, with a related
mortality of up to 80%. The most frequent risk factor is high-
dose corticosteroid use in solid organ transplantation, espe-
cially lung transplant [14]. Husain et al. reported an incidence
of nocardial infection of 2.1% in lung transplant recipients
[15]. Radiographic findings of pulmonary nocardiosis include
air-space consolidation (with a reported frequency of 64%),
variable-sized nodules (57%), masses (21%), pleural effusion
(28%), mediastinal and hilar lymphadenopathy (15%) [16].
Pulmonary lesions do not exhibit specific anatomic distribu-
tion and cavitation could be seen. In certain cases, differen-
tiating diagnosis is impossible between nocardia and TB
infections in lungs.
Other uncommon bacterial pathogens, such as Pseudo-
monas aeruginosa, Legionella pneumophila, and Rhodococcus
equi could cause severe pulmonary lesions in immunocom-
promised populations. Generally, consolidation, sometimes
with progression to cavitation, is the most frequent radio-
graphic finding [17]. Definitive diagnosis needs multidisci-
plinary efforts, blood test, sputum examination, imaging, and
even biopsy.
2. Fungal infection
The incidence of invasive fungal infections has dramati-
cally increased in the past two decades, in parallel to the
growing population of immunocompromised patients. Pneu-
mocystis jiroveci pneumonia (PJP) is the most common
infection in HIV-positive patients. P. jiroveci, previously
known as Pneumocystis carinii causing P. carinii pneumonia
(PCP), has been classified as a fungus. Abnormal chest ra-
diographs have been reported in up to 90% of patients with
suspected PJP. The typical findings include diffuse bilateral
symmetrical interstitial infiltrates, most marked in a perihilar
distribution [11]. However, the widespread use of prophylaxis
therapy has reduced the incidence and severity of classic im-
aging findings. Unusual presentations include unilateral dis-
ease, focal consolidation, and linear densities. CT findings
include ground-glass opacity and interlobular septal thick-
ening e sometimes combining to form a ‘crazy pavingpattern’. Less common manifestations include consolidation
and thin-walled cysts or pneumatoceles. Cysts may develop
during treatment for pneumocystis as well as at presentation of
the initial disease, seen in up to 10% of the cases and mainly
located in the upper lobe. The presence of cysts and crazy
paving patterns could be helpful to differentiating PJP from
hypersensitivity pneumonitis. Pleural effusions and lymph-
adenopathy are uncommon. HRCT has a high sensitivity and
specificity for PJP, 100% and 89%, respectively [18]. The
hallmark HRCT findings include diffuse or widespread ground
glass attenuation seen in over 90% of cases and mosaic dis-
tribution due to alveolar accumulation of fibrin and debris. In
addition, history of immunosuppression, especially AIDS,
favors the diagnosis of PJP.
Immunocompromised patients, particularly neutropenic
patients, are at high risk of developing invasive aspergillosis,
involving lungs and extrapulmonary organs. To facilitate the
diagnosis of invasive pulmonary aspergillosis for prompt
institution of specific therapy and reducing disease dissemi-
nation, the European Organisation for the Research and
Treatment of Cancer/Mycoses Study Group (EORTC/MSG)
proposed a classification based on host, clinical, and micro-
biologic factors [19]. The pulmonary manifestations of
aspergillosis can be divided into three categories: (1) semi-
invasive (chronic necrotizing) aspergillosis, (2) angioinvasive
aspergillosis, and (3) airway invasive aspergillosis (aspergillus
bronchopneumonia). Each category has relatively distinct
imaging characteristics. In semi-invasive aspergillosis, the
characteristic CT findings consist of unilateral or bilateral
segmental areas of consolidation or multiple nodular opacities
or both, which make reactivation tuberculosis a differentiating
diagnosis [20]. The most common manifestations in angioin-
vasive aspergillosis include Halo sign (i.e. nodules surrounded
by a halo of ground-glass attenuation) or pleural based wedge-
shaped areas of consolidation, reflecting hemorrhagic infarcts
[21]. Airway invasive aspergillosis could have various imaging
manifestations ranging from normal appearance to con-
solidative pneumonia, depending on the extent and severity of
involved airway. HRCT enables better characterization of
small airway diseases. Common findings include centrilobular
nodules and branching linear or nodular opacities, i.e. tree-in-
bud pattern. Consolidation could be in peribronchial distri-
bution [22].
Other opportunistic fungal infections include cryptococcal
pneumonia, histoplasmosis and candidiasis. Cryptococcus
neoformans can infect immunocompromised patient usually
when CD4 count is less than 100 cells/mm3. Central nervous
system is the commonest affected organ. The most common
radiographic abnormalities of cryptococcal pneumonia consist
of a reticular or reticulonodular interstitial pattern, suggestive
of interstitial infiltration, while ground-glass attenuation, air-
space consolidation, and miliary nodules are less frequently
seen [23]. CT pattern in immunocompromised non-AIDS pa-
tients seems to differ from that in AIDS patients by the
presence of nodules and the absence of reticular or retic-
ulonodular interstitial infiltrates [24]. Histoplasmosis occurs in
approximately 2% of AIDS patients, the majority of which
Table 2
Imaging findings of pneumonia caused by fungi and virus in immunocompromised patients.
Common radiographic findings Common CT findings
Pneumocystis pneumonia  Bilateral symmetric ground-glass opacities or fine reticulonodular
pattern, mainly involving perihilar regions.
 May be diffuse or involve mainly the lower or upper lung zones
 Bilateral symmetric ground-glass opacities
 May be patchy or diffuse
 May have “crazy paving” pattern
Pulmonary candidiasis  Unilateral or bilateral areas of consolidation
 Poorly defined nodules
 Multiple bilateral nodules
 CT halo sign
 Patchy or confluent consolidation
Angioinvasive pulmonary
aspergillosis
 Bilateral poorly defined nodules
 Single or multiple foci of consolidation
 Multiple nodules, 1e3 cm diameter
 CT halo sign
 Wedge-shaped areas of consolidation
 Cavitation, with or without air-crescent sign
Pulmonary histoplasmosis  Single or multiple nodules
 Unilateral or bilateral areas of consolidation
 Cavitation is rare
 Diffuse nodular opacities 3 mm or less in diameter
 Nodules greater than 3 mm in diameter
 Small linear opacities
 Focal or patchy areas of consolidation
cavitation is rare
Viral pulmonary infections  Bilateral reticulonodular pattern
 Patchy bilateral areas of consolidation
 Multiple small centrilobular nodules
 Unilateral or bilateral
 Patchy areas of consolidation
 Ground-glass opacities
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mosis may present initially with normal chest radiograph (up
to 40% of infected patients), but as the disease progresses,
nodular infiltrates and focal or patchy consolidation manifest,
mimicking the appearances of tuberculosis [25]. Cavitation
rarely occurs in histoplasmosis. Pulmonary candidiasis is
relatively uncommon and liver transplant recipients are sus-
ceptible to invasive candidiasis. With the widespread pro-
phylactic use of fluconazole and antibiotics, more non-
albicans candidiasis occurs with dread mortality. Thus, pro-
phylaxis therapy with extreme caution is necessary and should
be restricted to patients with high risks of complicated in-
fections [26]. Chest radiographic abnormalities consist of
patchy areas of consolidation, focal cavitation, and multiple
pulmonary nodules.
3. Viral infections
Cytomegalovirus (CMV) remains the most common path-
ogen and responsible for up to 50% of immunocompression-
related viral pneumonia [27]. In comparison to immunocom-
petent population, immunocompromised patients are more
prone to viral infections, particularly for those with T-cell
defect. However, the range of radiological signs of CMV
pneumonia is not subject to the host immune status. Common
imaging features include unilateral or bilateral interstitial in-
filtrates, alveolar consolidation, ground-glass opacities and
nodular opacities. Some of signs overlap with infections with
pneumocystis, although pleural effusions are more common in
CMV pneumonia [28].
During the past decade, respiratory viruses, including
rhinovirus, adenovirus, influenza, parainfluenza and respira-
tory syncytial virus, have been more frequently detected as
pathogens of deadly infections in immunocompromised pa-
tients with thanks to development of sophisticated molecular
diagnostic tools. Additionally, herpes simplex virus may
possibly cause a pneumonitis or a focal pneumonia inimmunosuppressed. Changes on the chest radiography may be
secondary to coexisting bacterial infection as well as due to
the primary effect of the virus itself and include bibasal air-
space consolidation, peripheral reticular/alveolar infiltrates,
and perihilar infiltrates [17].
Table 2 summarizes major imaging findings of fungal and
viral pneumonia commonly encountered in immunocompro-
mised patients.
4. Perspective
Past three decades witness great advancement in the med-
ical management of immunocompromised patients, which
dramatically improve patients' quality of life and influence
clinical courses to some extent. However, pulmonary in-
fections remain leading causes of morbidity and mortality in
immunocompromised patients. Classic clinical manifestations
of pulmonary diseases become less common, while non-spe-
cific and intertwined symptoms and complications are
increasingly encountered with heterogeneous imaging fea-
tures, demanding more multidisciplinary collaboration for
accurate management decision making than ever. Despite that
imaging findings overlaps and specific characteristics lack for
most of infectious diseases, imaging examinations, especially
CT and HRCT, play critical roles in providing enormous in-
formation regarding pulmonary conditions, etiological differ-
entiation and treatment response. Advancement in imaging
techniques will further improve diagnosis accuracy and timely
management, thereby reducing the mortality and morbidity
from respiratory diseases.
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